Nano-Based Delivery Systems for Topical Applications

Dear Colleagues,

Nanotechnology had gained momentum again after the emergence of the COVID-19 pandemic, with several vaccines being developed with nanoparticle delivery systems. The work of nanotechnology has been widely investigated for systemic administration; however, the nature of the nanometric size range highlights the great promise nanotechnology can offer to topical drug administration. The extreme small particle size that enables tight adherence to surfaces, complete coverage of the application area, and, in parallel, the versatility of sizes and compositions for better interaction and penetration upon topical application have extended nanoparticles usage from cosmetics to pharmaceuticals and from small to large molecules. This Special Issue aims to gather a selection of novel research in the area of nanoparticles’ topical delivery for pharmaceutical scientists in academia and industry to explore nanoparticles in topical delivery further and in more depth, making use of those unique systems to tackle complex topical diseases such psoriasis, atopic dermatitis, conjunctivitis, and otitis.  

I am pleased to invite you to contribute to this Special Issue, entitled “Nano-Based Delivery Systems for Topical Applications”. In this Special Issue, we aim to shed light on novel topical drug delivery cases that are based on the design and application of nanotechnology from formulation development to in vitro and in vivo preclinical formulation assessment. The scope of this Special Issue is to cover the main topical diseases of interest, such as topical caners, topical autoimmune diseases, and the use of nanoparticles in cosmetics.

In this Special Issue, original research articles and reviews are welcome to be submitted. Research areas may include, but are not limited to, the following:

1. Nanoparticles designed for better skin interaction;
2. Nanoparticles for drug delivery to nails;
3. Nanoparticles for topical ocular conditions;
4. The use of nanoparticles as drug delivery systems for topical cancers and autoimmune diseases, such as psoriasis.

I look forward to receiving your contributions.

Prof. Dr. Jelena Filipović-Grčić
Dr. Taher Hatahet
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.